stoxline Quote Chart Rank Option Currency Glossary
  
Inozyme Pharma, Inc. (INZY)
5.71  0.17 (3.07%)    02-23 16:00
Open: 5.53
High: 5.77
Volume: 341,588
  
Pre. Close: 5.54
Low: 5.49
Market Cap: 353(M)
Technical analysis
2024-02-23 4:37:30 PM
Short term     
Mid term     
Targets 6-month :  7.01 1-year :  8.19
Resists First :  6.01 Second :  7.01
Pivot price 5.58
Supports First :  4.83 Second :  4.11
MAs MA(5) :  5.69 MA(20) :  5.52
MA(100) :  4.08 MA(250) :  4.71
MACD MACD :  0.2 Signal :  0.3
%K %D K(14,3) :  57.3 D(3) :  63.2
RSI RSI(14): 60.4
52-week High :  7.32 Low :  2.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ INZY ] has closed below upper band by 34.2%. Bollinger Bands are 23.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.77 - 5.81 5.81 - 5.84
Low: 5.41 - 5.45 5.45 - 5.49
Close: 5.65 - 5.71 5.71 - 5.77
Company Description

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Headline News

Wed, 07 Feb 2024
INZY Stock Quote Price and Forecast - CNN

Tue, 06 Feb 2024
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Mon, 29 Jan 2024
Inozyme Pharma, Inc. (NASDAQ:INZY) Short Interest Update - MarketBeat

Thu, 21 Dec 2023
Institutional investors own a significant stake of 45% in Inozyme Pharma, Inc. (NASDAQ:INZY) - Yahoo Finance

Mon, 27 Nov 2023
Inozyme: A Major Catalyst Is Uncomfortably Far Off (NASDAQ:INZY) - Seeking Alpha

Thu, 09 Nov 2023
Inozyme Pharma to Participate in Upcoming Investor Conferences - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 62 (M)
Shares Float 34 (M)
Held by Insiders 0.6 (%)
Held by Institutions 92.7 (%)
Shares Short 2,870 (K)
Shares Short P.Month 3,070 (K)
Stock Financials
EPS -1.45
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.58
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -25.2 %
Return on Equity (ttm) -46.3 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.16
Qtrly Earnings Growth 0 %
Operating Cash Flow -67 (M)
Levered Free Cash Flow -44 (M)
Stock Valuations
PE Ratio -3.97
PEG Ratio -0.4
Price to Book value 2.2
Price to Sales 0
Price to Cash Flow -5.3
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android